NewAmsterdam Pharma Company N.V.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2023 | $58.7M | $347.1M | $340.5M |
| Mar 2024 | $76.7M | $488.5M | — |
| Jun 2024 | $59.3M | $446.7M | — |
| Sep 2024 | $60.3M | $439.2M | $422.7M |
| Dec 2024 | $107.1M | $864.6M | $771.7M |
| Mar 2025 | $41.1M | $818.4M | $748.4M |
| Jun 2025 | $36.6M | $815.1M | $563.9M |
| Sep 2025 | $58.4M | $786.4M | $538.4M |
| Dec 2025 | $85.9M | $769.3M | $490.0M |
| Mar 2026 | $67.4M | $732.6M | $457.6M |
| Jun 2026 | $73.0M | $704.5M | $424.2M |